Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Accured Expenses (2016 - 2025)

Bio-Techne has reported Change in Accured Expenses over the past 17 years, most recently at -$18.6 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$18.6 million for Q4 2025, down 253.31% from a year ago — trailing twelve months through Dec 2025 was -$38.5 million (down 446.68% YoY), and the annual figure for FY2025 was -$14.0 million, down 210.59%.
  • Change in Accured Expenses for Q4 2025 was -$18.6 million at Bio-Techne, down from -$2.1 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for TECH hit a ceiling of $13.9 million in Q1 2021 and a floor of -$26.0 million in Q2 2025.
  • Median Change in Accured Expenses over the past 5 years was $188500.0 (2022), compared with a mean of $179650.0.
  • Biggest five-year swings in Change in Accured Expenses: surged 377.06% in 2021 and later tumbled 575.63% in 2025.
  • Bio-Techne's Change in Accured Expenses stood at -$8.1 million in 2021, then decreased by 25.11% to -$10.1 million in 2022, then skyrocketed by 179.65% to $8.1 million in 2023, then skyrocketed by 50.15% to $12.1 million in 2024, then plummeted by 253.31% to -$18.6 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$18.6 million (Q4 2025), -$2.1 million (Q3 2025), and -$26.0 million (Q2 2025) per Business Quant data.